Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Witkiewicz, Agnieszka K., McMillan, Elizabeth A., Balaji, Uthra, Baek, GuemHee, Lin, Wan-Chi, Mansour, John, Mollaee, Mehri, Wagner, Kay-Uwe +7 more·2015·Nature Communications

DOI 10.1038/ncomms7744

Cited by (1,000)

Items 401–500 of 1,000

Molecular alterations in pancreatic tumors
Michela Visani, Giorgia Acquaviva, Antonio De Leo, Viviana Sanza, Lidia Merlo, Thais Maloberti, Alba Ariela Brandes, Enrico Franceschi, Monica Di Battista, Michele Masetti et al. · 2021 · World Journal of Gastroenterology
ParsVNN: parsimony visible neural networks for uncovering cancer-specific and drug-sensitive genes and pathways
Xiaoqing Huang, Kun Huang, Travis S. Johnson, Milan Radovich, Jie Zhang, Jianzhu Ma, Yijie Wang · 2021 · NAR Genomics and Bioinformatics
Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion
Yea Ji Jeong, Hildur Knútsdóttir, Fatemeh Shojaeian, Michael G. Lerner, Maria F. Wissler, Elodie Henriet, Tammy Ng, Shalini Datta, Bernat Navarro-Serer, Peter E. Chianchiano et al. · 2023 · Journal of Clinical Investigation
Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC
Charles P. Hinzman, Leala Aljehane, Joshua D. Brown-Clay, Bhaskar Kallakury, Fuminori Sonahara, Ajay Goel, Jose Gilberto Trevino, Partha P. Banerjee · 2018 · Carcinogenesis
Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles
Lakkakula VKS Bhaskar, Batoul Farran, Saikrishna Lakkakula, Sujatha Peela, Nagendra Sastry Yarla, Pallaval Veera Bramhachari, Mohammad Amjad Kamal, Madhu Sudhana Saddala, Ganji Purnachandra Nagaraju · 2018 · Seminars in Cancer Biology
Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging
Karin Hestnes Edland, Kjersti Tjensvoll, Satu Oltedal, Ingvild Dalen, Morten Lapin, Herish Garresori, Nils Idar Glenjen, Bjørnar Gilje, Oddmund Nordgård · 2023 · Molecular Oncology
Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment
Szu-Aun Long, Amber M. Amparo, Grace Goodhart, Syed Ameen Ahmad, Andrew M. Waters · 2024 · Frontiers in Oncology
Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer
Haiwei Wang, Xinrui Wang, Liangpu Xu, Yingying Lin, Ji Zhang, Hua Cao · 2020 · Aging
Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion
Rebecca A. Sorber, Yaroslav Teper, Abisola Abisoye-Ogunniyan, Joshua J. Waterfall, Sean R. Davis, J. Keith Killian, Marbin A. Pineda, Satyajit Ray, Matthew McCord, Holger Pflicke et al. · 2016 · PLoS ONE
Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression
Zhang Li, Chenghao Shao, Xiaoxiao Liu, Xiaojing Lu, Xiaona Jia, Xufen Zheng, Simin Wang, Li Zhu, Ke Li, Yuzhi Pang et al. · 2019 · Carcinogenesis
Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation
Valentyna Kryklyva, Esther ter Linden, Leonie I. Kroeze, Richarda M. de Voer, Berit Kolk, Martijn W.J. Stommel, John J. Hermans, Claudio Luchini, Laura DeLong Wood, Ralph H. Hruban et al. · 2020 · Pancreas
RBM10, a New Regulator of p53
Ji Hoon Jung, Hyemin Lee, Shelya X. Zeng, Hua Lu · 2020 · Cells
The Evolutionary Forest of Pancreatic Cancer
Katelyn M. Mullen, Jungeui Hong, Marc A. Attiyeh, Akimasa Hayashi, Hitomi Sakamoto, Zachary A. Kohutek, Caitlin A. McIntyre, Haochen Zhang, Alvin P. Makohon-Moore, Amanda Zucker et al. · 2024 · Cancer Discovery
Molecular and Clinicopathological Differences by Age at the Diagnosis of Colorectal Cancer
Chu-Cheng Chang, Pei-Ching Lin, Chun‐Chi Lin, Yuan‐Tzu Lan, Hung‐Hsin Lin, Chien‐Hsing Lin, Shung-Haur Yang, Wen-Yi Liang, Wei-Shone Chen, Jeng‐Kai Jiang et al. · 2017 · International Journal of Molecular Sciences
Liver and Pancreas: Do Similar Embryonic Development and Tissue Organization Lead to Similar Mechanisms of Tumorigenesis?
Elsa Ghurburrun, Ivan Borbath, Frédéric P. Lemaigre, Patrick Jacquemin · 2018 · Gene Expression
A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets
Chao Chen, Qiming Zhou, Riping Wu, Bo Li, Qiang Chen, Xiuqing Zhang, Chunmei Shi · 2019 · BioMed Research International
Characterization of genetic subclonal evolution in pancreatic cancer mouse models
Noushin Niknafs, Yi Zhong, John Alec Moral, Lance Zhang, Melody Xiaoshan Shao, April Lo, Alvin P. Makohon-Moore, Christine A. Iacobuzio–Donahue, Rachel Karchin · 2019 · Nature Communications
Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing
Hongyun Ma, Bin Song, Shiwei Guo, Gang Li, Gang Jin · 2020 · Cancer Biomarkers
Tiny but mighty: use of next generation sequencing on discarded cytocentrifuged bile duct brushing specimens to increase sensitivity of cytological diagnosis
Aparna Harbhajanka, Claire W. Michael, Nafiseh Janaki, Hamza Numan Gokozan, Jay K. Wasman, Philip Bomeisl, Jennifer M. Yoest, Navid Sadri · 2020 · Modern Pathology
Evaluation and diagnostic value of next‐generation sequencing analysis of residual liquid‐based cytology specimens of pancreatic masses
Yoko Sekita‐Hatakeyama, Tomomi Fujii, Takeshi Nishikawa, Akira Mitoro, Masayoshi Sawai, Hiroe Itami, Kouhei Morita, Tomoko Uchiyama, Maiko Takeda, Masayuki Sho et al. · 2021 · Cancer Cytopathology
RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma
Yingyue Cao, Jianxiong Geng, Xin Wang, Qingwei Meng, Shanqi Xu, Yaoguo Lang, Yongxu Zhou, Lishuang Qi, Zijie Wang, Zixin Wei et al. · 2021 · International Journal of Biological Sciences
Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort
Qian Zhan, Chenlei Wen, Yi Zhao, Lu Fang, Yangbing Jin, Zehui Zhang, Siyi Zou, Fanlu Li, Ying Yang, Lijia Wu et al. · 2021 · EBioMedicine
Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression
Feifei Cheng, Xuejuan Wang, Yi‐Shiou Chiou, Chuyu He, Hui Guo, Yan Qin Tan, Basappa Basappa, Tao Zhu, Vijay Pandey, Peter Edward Lobie · 2022 · Cell Death and Disease
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients
Bruna Dalmasso, Alberto Puccini, Fabio Catalano, Roberto Borea, Maria Laura Iaia, William Bruno, Giuseppe Fornarini, Stefania Sciallero, Sara Elena Rebuzzi, Paola Ghiorzo · 2022 · International Journal of Molecular Sciences
Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in KRAS and BRAF Tumor Cells
Pui–Kei Wu, Seung‐Keun Hong, Jong‐In Park · 2017 · Molecular and Cellular Biology
Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer
William Berry, Joanne Lundy, Daniel Gerald Croagh, Brendan John Jenkins · 2018 · Cancers
Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma
Man Hung Choi, Eline Mejlænder-Andersen, Sophia Manueldas, Khadija El Jellas, Solrun Johanne Steine, Kjersti Tjensvoll, Hege Aase Sætran, Stian Knappskog, Dag Hoem, Oddmund Nordgård et al. · 2019 · BMC Cancer
Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment
Kyong‐Ah Yoon, Sang Myung Woo, Yun‐Hee Kim, Sun‐Young Kong, Min Kyoung Lee, Sung‐Sik Han, Tae Hyun Kim, Woo Jin Lee, Sang‐Jae Park · 2019 · Gut and Liver
GLP1 alleviates oleic acid-propelled lipocalin-2 generation by tumor-infiltrating CD8+ T cells to reduce polymorphonuclear MDSC recruitment and enhances viral immunotherapy in pancreatic cancer
Jingyi Wu, Peng Qian, Yifeng Han, Chuning Xu, Xia Mao, Ping Zhan, Jiwu Wei, Jie Dong · 2025 · Cellular and Molecular Immunology
Changing the course of pancreatic cancer – Focus on recent translational advances
Milind M. Javle, Talia Golan, Anirban Maitra · 2016 · Cancer Treatment Reviews
Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
Wenhao Luo, Gang Yang, Jiangdong Qiu, Jingyang Luan, Ying Zhang, Lei You, Mengyu Feng, Fangyu Zhao, Yueze Liu, Zhe Cao et al. · 2019 · Cancer Medicine
Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging
Ajaykumar C. Morani, Abdelrahman K. Hanafy, Nisha Subhashchandra Ramani, Venkata Subbiah Katabathina, Sireesha Yedururi, Anil K. Dasyam, Srinivasa R. Prasad · 2020 · Radiology Imaging Cancer
Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?
Chu Lee Wu, Ping Yang, Bingxue Liu, Yunlian Tang · 2020 · OncoTargets and Therapy
Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples
Alexander Semaan, Vincent Bernard, Jaewon James Lee, Justin Wong, Jonathan H. Huang, Daniel B. Swartzlander, Bret M. Stephens, Maria E. Monberg, Brian R. Weston, Manoop S. Bhutani et al. · 2020 · Clinical Cancer Research
3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma
Liu, Xinyuan, Gündel, Beate, Li, Xidan, Liu, Jianping, Wright, Anthony, Löhr, Matthias, Arvidsson, Gustav, Heuchel, Rainer · 2021 · Translational Oncology
Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
Xue-Song Xiang, Pengcheng Li, Wenquan Wang, Liang Liu · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
RNA Exosome Component EXOSC4 Amplified in Multiple Cancer Types Is Required for the Cancer Cell Survival
Kenzui Taniue, Tanzina Tanu, Yuki Shimoura, Shuhei Mitsutomi, Han Han, Rika Kakisaka, Yusuke Ono, Nobue Tamamura, Kenji Takahashi, Youichiro Wada et al. · 2022 · International Journal of Molecular Sciences
KRAS as a Key Oncogene in the Clinical Precision Diagnosis and Treatment of Pancreatic Cancer
Manxiong Dai, Shaofeng Chen, Xiong Teng, Kang Chen, Wei Cheng · 2022 · Journal of Cancer
Strategies for the drug discovery and development of taxane anticancer therapeutics
Changwei Wang, Angelo Aguilar, Iwao Ojima · 2022 · Expert Opinion on Drug Discovery
Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges
Zhichen Jiang, Xiaohao Zheng, Min Li, Mingyang Liu · 2023 · Frontiers of Medicine
ARID1A suppresses malignant transformation of human pancreatic cells via mediating senescence-associated miR-503/CDKN2A regulatory axis
Zhaoyun Li, Shanshan Zhu, Xian-jun Chen, Jie Zhu, Qi Chen, Yaqiong Zhang, Chunling Zhang, Tingting Guo, Liming Zhang · 2017 · Biochemical and Biophysical Research Communications
Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer
Belinda Lee, Peter Gibbs · 2019 · Journal of Personalized Medicine
A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients
Gourab Saha, Richa Singh, Argha Mandal, Subrata Kumar Das, Esita Chattopadhyay, Prasun Panja, Paromita Roy, Navonil De Sarkar, Sumit Gulati, Supriyo Ghatak et al. · 2020 · Molecular Medicine
Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer
Faustino Mollinedo, Consuelo Gajate · 2021 · Cancers
Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language.
Eriko Iguchi, Stephanie L. Safgren, David L. Marks, Rachel Olson, Martín E. Fernández-Zapico · 2016 · Europe PMC (PubMed Central)
PDAC as an immune evasive disease: can 3D model systems aid to tackle this clinical problem?
Narayanan, Shruthi, Vicent, Silve, Ponz-Sarvisé, Mariano · 2021 · Frontiers in Cell and Developmental Biology
Bioinformatory‐assisted analysis of next‐generation sequencing data for precision medicine in pancreatic cancer
Linnéa Malgerud, Johan Lindberg, Valtteri Wirta, Maria Gustafsson‐Liljefors, Masoud Karimi, Carlos Fernández Moro, Katrin Stecker, Alexander Picker, Carolin Huelsewig, Martin Stein et al. · 2017 · Molecular Oncology
Advances in the Genetics and Biology of Pancreatic Cancer
Andrew J. Aguirre, Eric Andrew Collisson · 2017 · The Cancer Journal
KRAS genotyping by digital PCR combined with melting curve analysis
Junko Tanaka, Tatsuo Nakagawa, Akiko Shiratori, Yuzuru Shimazaki, Chihiro Uematsu, Masao Kamahori, Takahide Yokoi, Kunio Harada, Yoshinobu Kohara · 2019 · Scientific Reports
Class III phosphatidylinositol 3-kinase complex I subunit NRBF2/Atg38 - from cell and structural biology to health and disease
Yohei Ohashi · 2021 · Autophagy
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer
Simone Furini, Chiara Falciani · 2021 · Frontiers in Oncology
KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases
Iris van ’t Erve, Nina J. Wesdorp, Jamie E. Medina, Leonardo Ferreira, Alessandro Leal, Joost Huiskens, Karen Bolhuis, Jan‐Hein T. M. van Waesberghe, Rutger‐Jan Swijnenburg, Daan A. van den Broek et al. · 2021 · JCO Precision Oncology
The Gut Microbiome and Pancreatic Cancer Development and Treatment
Holly Attebury, Donnele Daley · 2023 · The Cancer Journal
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer
Sébastien Martinez, Shifei Wu, Michael J. Geuenich, Ahmad Malik, Ramona Weber, Tristan Woo, Amy Xin Wei Zhang, Gun Ho Jang, Dzana Dervovic, Khalid N. Al‐Zahrani et al. · 2024 · Nature Communications
The need for effective pancreatic cancer detection and management: a biomarker-based strategy
Aoife S Crawley, Richard J O’Kennedy · 2015 · Expert Review of Molecular Diagnostics
MYC: A Stratification Marker for Pancreatic Cancer Therapy
Matthias Wirth, Günter Schneider · 2015 · Trends in cancer
Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression
Radim Moravec, Rao L. Divi, Mukesh Verma · 2017 · World Journal of Gastrointestinal Oncology
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)
Jordan D. Berlin, Yang Feng, Paul J. Catalano, James L. Abbruzzese, Philip A. Philip, Robert R. McWilliams, Andrew M. Lowy, Al B. Benson, A. William Blackstock · 2017 · Oncology
Induced PTF 1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment
Brad L. Jakubison, Patrick G. Schweickert, Sarah E. Moser, Yi Yang, Hongyu Gao, Kathleen M. Scully, Pamela Itkin‐Ansari, Yunlong Liu, Stephen F. Konieczny · 2018 · Molecular Oncology
The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer
Adriana Harbuzariu, Gabriela Oprea‐Ilies, Ruben Rene Gonzalez-Perez · 2018 · Medicines
Silver-Nanoparticle-Mediated Therapies in the Treatment of Pancreatic Cancer
Rachel Foulkes, Mohsen Ali Asgari, Anthony D. M. Curtis, Clare Hoskins · 2019 · ACS Applied Nano Materials
Molecular Targeting of a BRAF Mutation in Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review
An-Katrien Seghers, Pieter-Jan AR Cuyle, Eric Van Cutsem · 2020 · Targeted Oncology
From Genomic Exploration to Personalized Treatment: Next-Generation Sequencing in Oncology
Vishakha Vashisht, Ashutosh Vashisht, Ashis Kumar Mondal, Jana Woodall, Ravindra B Kolhe · 2024 · Current Issues in Molecular Biology
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
Carla Mottini, Hideo Tomihara, Diego Carrella, Alessia Lamolinara, Manuela Iezzi, Justin Kwang-Lay Huang, Carla Azzurra Amoreo, Simonetta Buglioni, Isabella Manni, Frederick Scott Robinson et al. · 2019 · Cancer Research
Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
Katharina Lankes, Zonera Hassan, Josefina Doffo, Christian Schneeweis, Svenja Lier, Rupert Öllinger, Roland Rad, Oliver Holger Krämer, Ulrich Bernd Keller, Dieter Saur et al. · 2020 · Molecular Oncology
Drivers of Gene Expression Dysregulation in Pancreatic Cancer
Swati Venkat, Abdulrahman A. Alahmari, Michael E. Feigin · 2021 · Trends in cancer
Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
Hiromitsu Hayashi, Norio Uemura, Zhao Liu, Kazuki Matsumura, Hiroki Sato, Yuta Shiraishi, Hideo Andreas Baba · 2021 · Frontiers in Oncology
KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer
Tatsunori Suzuki, Yohei Masugi, Yosuke Inoue, Tsuyoshi Hamada, Mariko Hori Tanaka, Manabu Takamatsu, Junichi Arita, Tomotaka Kato, Yoshikuni Kawaguchi, Akiko Kunita et al. · 2022 · Cancer Science
Pancreatic Cancer Chemoprevention Translational Workshop
Mark Steven Miller, Peter Allen, Teresa A. Brentnall, Michael Goggins, Ralph H. Hruban, Gloria M. Petersen, Chinthalapally V. Rao, David Clement Whitcomb, Randall E. Brand, Suresh T. Chari et al. · 2016 · Pancreas
GLI1, a master regulator of the hallmark of pancreatic cancer
Kenji Kasai · 2016 · Pathology International
Phosphorylation of LSD1 by PLK1 promotes its chromatin release during mitosis
Bin Peng, R. Shi, Weiwei Jiang, Yue‐He Ding, Meng‐Qiu Dong, Wei‐Guo Zhu, Xingzhi Xu · 2017 · Cell & Bioscience
A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic Cancer
Charlotte K. Milton, Annette J. Self, Paul Andrew Clarke, Udai Banerji, Federica Piccioni, David E. Root, Steven R. Whittaker · 2020 · Molecular Cancer Therapeutics
Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines
Plangger, Adelina, Rath, Barbara, Stickler, Sandra, Hochmair, Maximilian, Lang, Clemens, Weigl, Lukas, Funovics, Martin, Hamilton, Gerhard · 2022 · Discover Oncology
A New Strategy to Control and Eradicate “Undruggable” Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Robert E. Van Sciver, Michael Lee, Caroline Guat Lay Lee, Alex Lafever, Elizaveta A. Svyatova, Kevin Kanda, Amber L. Collier, Lauren L. Siewertsz van Reesema, Angela M. Tang-Tan, Vasilena P. Zheleva et al. · 2018 · Cancers
Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification
Vincenzo Nasca, Marta Chiaravalli, Geny Piro, Annachiara Esposito, Lisa Salvatore, Giampaolo Tortora, Vincenzo Corbo, Carmine Carbone · 2020 · International Journal of Molecular Sciences
The Neutrophil-to-Monocyte Ratio and Platelet-to-White Blood Cell Ratio Represent Novel Prognostic Markers in Patients with Pancreatic Cancer
Feng Tang, Penghui Dai, Qiongqiong Wei, Ke Gan, Zijie Wang, Huan Chen, Ting Li, Muhan Lv, Mingming Deng, Gang Luo · 2021 · Gastroenterology Research and Practice
First international workshop of the ATM and cancer risk group (4-5 December 2019)
Fabienne Lesueur, Douglas F. Easton, Anne‐Laure Renault, Sean V. Tavtigian, Jonine L. Bernstein, Zsofia Kote‐Jarai, Rosalind A. Eeles, Dijana Plaseska-Karanfia, Lídia Feliubadaló, Spanish ATM working group et al. · 2021 · Familial Cancer
TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma
Joanne Lundy, Linden J. Gearing, Hugh Gao, Alison C. West, Louise McLeod, Virginie Deswaerte, Liang Yu, Sean R. Porazinski, Marina Pajic, Paul J. Hertzog et al. · 2021 · Oncogene
Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in Pancreatic Cancer
Lei Feng, Jieqing Wang, Jianmin Zhang, Jingfang Diao, Longguang He, Chaoyi Fu, Hui Liao, Xiaoping Xu, Yi Gao, Chenjie Zhou · 2021 · Frontiers in Cell and Developmental Biology
Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines
Yixuan Ma, Benjamin Schulz, Nares Trakooljul, Moosheer Alammar, Anett Sekora, Sina Sender, Frieder Hadlich, Dietmar Zechner, Frank Ulrich Weiß, Markus M. Lerch et al. · 2022 · Cancers
Clinical update on K-Ras targeted therapy in gastrointestinal cancers
Shubham Pant, Joleen Marie Hubbard, Erika Martinelli, Tanios Bekaii‐Saab · 2018 · Critical Reviews in Oncology/Hematology
Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication
Yu-Hsuan Hung, Ming-Chuan Hsu, Li-Tzong Chen, W. Hung, Mei-Ren Pan · 2019 · Journal of Clinical Medicine
High glypican‑1 expression is a prognostic factor for predicting a poor clinical prognosis in patients with hepatocellular carcinoma
Guoyong Chen, Hao Wu, Lei Zhang, Sidong Wei · 2020 · Oncology Letters
Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel
Thomas P. Brouwer, Alexander L. Vahrmeijer, Noel F.C.C. de Miranda · 2021 · Cellular Oncology
Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
Graziana Digiacomo, Francesco Volta, Ingrid Garajová, Rita Balsano, Andrea Cavazzoni · 2021 · Life
Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
Remya P. G. Ramesh, Hadida Yasmin, Pretty Ponnachan, Basel K. al-Ramadi, Uday Kishore, Ann Mary Joseph · 2025 · Frontiers in Immunology
Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions
Mark G. Ettel, Lili Zhao, Shula A. Schechter, Jiaqi Shi · 2019 · Pathology
Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer
Shinichi Takano, Mitsuharu Fukasawa, Makoto Kadokura, Hiroko Shindo, Ei Takahashi, Sumio Hirose, Yoshimitsu Fukasawa, Satoshi Kawakami, Hiroshi Hayakawa, Shinya Maekawa et al. · 2019 · Pancreas
Integrated multi‐omics data analyses for exploring the co‐occurring and mutually exclusive gene alteration events in colorectal cancer
Yuan Zhou, Xiaoqing Cheng, Fenglan Zhang, Qingqing Chen, Xinyu Chen, Yaojia Shen, Chong Lai, Vishnu Goutham Kota, Wenjie Sun, Qiong Huang et al. · 2020 · Human Mutation
Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
Panagiotis Sarantis, Alexandros Bokas, Adriana Papadimitropoulou, Evangelos Koustas, Stamatios E Theocharis, Pavlos Papakotoulas, Dimitriοs Schizas, Alexandros Papalampros, Evangelos S. Felekouras, Athanasios G. Papavassiliou et al. · 2021 · International Journal of Molecular Sciences
Circulating tumor DNA in molecular assessment feasibly predicts early progression of pancreatic cancer that cannot be identified via initial imaging
Fumiaki Watanabe, Koichi Suzuki, Hidetoshi Aizawa, Yuhei Endo, Yuji Takayama, Nao Kakizawa, Takaharu Kato, Hiroshi Noda, Toshiki Rikiyama · 2023 · Scientific Reports
Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer
Hideki Motobayashi, Yuji Kitahata, Ken‐ichi Okada, Motoki Miyazawa, Masaki Ueno, Shinya Hayami, Atsushi Miyamoto, Atsushi Shimizu, Masatoshi Sato, Tomohiro Yoshimura et al. · 2024 · Journal of Cancer Research and Clinical Oncology
Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer
Yang Gao, Yayun Zhu, Zhou Yuan · 2016 · International Journal of Medical Sciences
Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis—A connection to licensing nodes
Christian Schneeweis, Matthias Wirth, Dieter Saur, Maximilian Reichert, Günter Schneider · 2016 · Small GTPases
Molecular therapeutics in pancreas cancer
Vignesh Narayanan, Colin D. Weekes · 2016 · World Journal of Gastrointestinal Oncology
Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards personalized medicine
Renato Micelli Lupinacci, Jean‐Baptiste Bachet, Thierry André, Alex Duval, Magali Svrcek · 2018 · Surgical Oncology
ClinGen Cancer Somatic Working Group – standardizing and democratizing access to cancer molecular diagnostic data to drive translational research
Subha Madhavan, Deborah Ritter, Christine Micheel, Shruti Rao, Angshumoy Roy, Dmitriy Sonkin, Matthew McCoy, Malachi Griffith, Obi L. Griffith, Peter B. McGarvey et al. · 2017 · Pacific Symposium on Biocomputing (PSB)
Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy
Meng Zhang, Changsong Qi, Zhenghang Wang, Hui Chen, Xiaochen Zhao, Xueming Zhang, Yifan Zhou, Chan Gao, Yuezong Bai, Shuqin Jia et al. · 2021 · Journal of Molecular Medicine
Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management
Daniel Schreyer, John P. Neoptolemos, Simon T. Barry, Peter Bailey · 2022 · Frontiers in Cell and Developmental Biology
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer
Adam L. Burrack, Zoe C. Schmiechen, Michael T. Patterson, Ebony A. Miller, Ellen J. Spartz, Meagan R. Rollins, Jackson F. Raynor, Jason S. Mitchell, Tsuneyasu Kaisho, Brian T. Fife et al. · 2022 · JCI Insight